Detalles de la búsqueda
1.
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.
Lupus
; 33(6): 615-628, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545763
2.
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.
Rheumatology (Oxford)
; 62(12): 3916-3923, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946293
3.
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(12): 4752-4762, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302581
4.
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.
Rheumatology (Oxford)
; 60(9): 4205-4217, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33404659
5.
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(3): 1260-1272, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918459
6.
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(10): 4703-4716, 2021 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502473
7.
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
Rheumatology (Oxford)
; 58(12): 2170-2176, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157891
8.
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1102-1107, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28356243
9.
Established organ damage reduces belimumab efficacy in systemic lupus erythematosus.
Ann Rheum Dis
; 78(7): 1006-1007, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610063
10.
Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.
Front Med (Lausanne)
; 10: 1247354, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37692782
11.
How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.
J Clin Med
; 11(7)2022 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407466
12.
EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.
Front Med (Lausanne)
; 9: 1092325, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606059
13.
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.
Front Med (Lausanne)
; 8: 651249, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937290
14.
Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
J Clin Med
; 9(6)2020 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532059
15.
Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.
Expert Opin Biol Ther
; 19(2): 157-168, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30571926
16.
Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trials.
Lancet Rheumatol
; 1(3): e163-e173, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229393
17.
Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.
RMD Open
; 2(2): e000323, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27651929
Resultados
1 -
17
de 17
1
Próxima >
>>